Flexion Therapeutics Announces Agreements with Four Major ... - Forbes

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service25 times read : Adjust font size: Decrease font Enlarge font
image

The agreements with AstraZeneca, Merck Serono (a division of Merck KGaA, Darmstadt, Germany) and one other partner establish for Flexion a mature pipeline of clinically enabled drug candidates focused on inflammatory diseases. An investment from ...

Read this article...



Post your comment comment Comments (0 posted)

More News

copyright